This study revealed the cross downregulation between CDK6 and PI3K in cdk6 deficient cancer cell populations, demonstrated that CDK6-PI3K axis could be new target for inhibiting ABCB1-mediated MDR. The gene discussed is PIK3CB; the disease is cancer.